The most commonly prescribed form of treatment in COPD is inhalation therapy, including inhalers and nebulizers. The fast and effective relief of symptoms from a nebulizer can greatly improve your quality of life and even reduce the number of emergencies you have.

Emphysema is a lung condition that causes shortness of breath. In people with emphysema, the air sacs in the lungs (alveoli) are damaged. Over time, the inner walls of the air sacs weaken and rupture — creating larger air spaces instead of many small ones.

Emphysema causes damage to the air sacs in the lungs and the walls between them. This causes the sacs to lose their stretchiness and trap air instead. It becomes increasingly difficult to expel all air from the lungs, and they no longer empty efficiently. This leads to the presence of more air than usual.

Both devices are equally effective, though there are advantages and disadvantages to each. For example, inhalers leave more room for user error, but they allow you to act quickly. 1 Nebulizers can’t be easily accessed on the go, but can be used for longer durations.

Advair is one of the most commonly used inhalers for the maintenance treatment of COPD. It is a combination of fluticasone, a corticosteroid, and salmeterol, a long-acting bronchodilator. Advair is used on a regular basis for the maintenance treatment of COPD and it is typically taken twice per day.

For most people with COPD, short-acting bronchodilator inhalers are the first treatment used. Bronchodilators are medicines that make breathing easier by relaxing and widening your airways. There are 2 types of short-acting bronchodilator inhaler: beta-2 agonist inhalers – such as salbutamol and terbutaline.

Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.